Human Genetics

Biography

Biography: Purvi Patel M.S.

Abstract

Next Generation sequencing technologies, via vast data enabling, will provide a comprehensive picture of the human genome variation in the future. Here we present a novel consolidated approach for Next Generation Sequencing in the management of cancers. Nowadays, the advent of high-throughput next generation sequencing (NGS) technologies transforming genomics and transcriptomics by providing a single base resolution tool for an in-depth consolidated analysis of diseases complexity and allowing a fast and cost-efficient fine-scale assessment of the genetic variability hidden within cohorts of patients affected by the same cancer type. Therefore, NGS strategies promise to play a crucial role in the selection of tailored therapeutic approaches. UID created a platform of physicians and scientists wherein a consolidated approach was pursued. We demonstrated the utility of genomic information to improve clinical outcomes of cancers, as well as of translation of genomic data, essential to predict and personalize clinical applications to routine clinical practice. This included testing for cancers and analysis of the bioinformatics information by a panel of physicians and geneticists that would be involved with providing suggestions and clinical treatment parameters for the patient. UID proposes an extensive E-learning initiative to train physicians to understand Next Generation Sequencing results. The platform also entails a robust patient engagement model for patient and improving clinical outcomes overall.